{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:17:11Z","timestamp":1792016231468,"version":"4.4.0"},"reference-count":146,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":933,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.neuron.2010.12.035","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T06:38:16Z","timestamp":1297319896000},"page":"423-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"title":["Huntington's Disease: Can Mice Lead the Way to Treatment?"],"prefix":"10.1016","volume":"69","author":[{"given":"Zachary R.","family":"Crook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Housman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2010.12.035_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2010.12.035_bib2","series-title":"Huntington's Disease","author":"Bates","year":"2002"},{"key":"10.1016\/j.neuron.2010.12.035_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2010.12.035_bib4","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1523\/JNEUROSCI.11-06-01649.1991","article-title":"Chronic quinolinic acid lesions in rats closely resemble Huntington's disease","volume":"11","author":"Beal","year":"1991","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib5","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","article-title":"Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid","volume":"13","author":"Beal","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib6","doi-asserted-by":"crossref","first-page":"e5747","DOI":"10.1371\/journal.pone.0005747","article-title":"Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6\/2 mouse model of Huntington's disease","volume":"4","author":"Benn","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuron.2010.12.035_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature06022","article-title":"Global changes to the ubiquitin system in Huntington's disease","volume":"448","author":"Bennett","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2010.12.035_bib8","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bj\u00f6rkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.neuron.2010.12.035_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.neuron.2010.12.035_bib10","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/hmg\/8.9.1647","article-title":"Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin","volume":"8","author":"Boutell","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib11","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib12","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","article-title":"Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease","volume":"93","author":"Brustovetsky","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2010.12.035_bib13","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajmg.b.20110","article-title":"The gender effect in juvenile Huntington disease patients of Italian origin","volume":"125B","author":"Cannella","year":"2004","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib14","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1523\/JNEUROSCI.19-08-03248.1999","article-title":"Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation","volume":"19","author":"Carter","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib15","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/hmg\/11.17.1939","article-title":"Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's disease","volume":"11","author":"Chan","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/77528","article-title":"Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease","volume":"6","author":"Chen","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuron.2010.12.035_bib17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.870120319","article-title":"A controlled trial of fluoxetine in nondepressed patients with Huntington's disease","volume":"12","author":"Como","year":"1997","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuron.2010.12.035_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","article-title":"Controlled clinical trial of cannabidiol in Huntington's disease","volume":"40","author":"Consroe","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuron.2010.12.035_bib19","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2010.12.035_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2010.12.035_bib21","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/hmg\/ddl224","article-title":"Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of Huntington's disease","volume":"15","author":"Cummings","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainresbull.2006.10.016","article-title":"Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease","volume":"72","author":"Cummings","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuron.2010.12.035_bib23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.nbd.2004.08.009","article-title":"Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice","volume":"17","author":"Cybulska-Klosowicz","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2010.12.035_bib24","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0092-8674(00)80513-9","article-title":"Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation","volume":"90","author":"Davies","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2010.12.035_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2006.12.004","article-title":"Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease","volume":"178","author":"Dorner","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2010.12.035_bib26","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1126\/science.1072613","article-title":"Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease","volume":"296","author":"Dunah","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuron.2010.12.035_bib27","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib28","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib29","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib30","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1471-2377-9-62","article-title":"Tetrabenazine as anti-chorea therapy in Huntington disease: An open-label continuation study","volume":"9","author":"Frank","year":"2009","journal-title":"BMC Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuron.2010.12.035_bib32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.brainresrev.2008.12.001","article-title":"The R6 lines of transgenic mice: A model for screening new therapies for Huntington's disease","volume":"59","author":"Gil","year":"2009","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.neuron.2010.12.035_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain","volume":"23","author":"Gin\u00e9s","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: A comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2010.12.035_bib35","first-page":"263","article-title":"L-acetyl-carnitine in Huntington's disease: Double-blind placebo controlled crossover study of drug effects on movement disorder and dementia","volume":"5","author":"Goetz","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuron.2010.12.035_bib36","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/00001756-199806010-00028","article-title":"Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset","volume":"9","author":"Gourfinkel-An","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuron.2010.12.035_bib37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","article-title":"Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin","volume":"125","author":"Graham","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2010.12.035_bib38","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","article-title":"Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease","volume":"29","author":"Graham","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib39","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib40","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/j.1460-9568.2005.04365.x","article-title":"Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine","volume":"22","author":"Grote","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib41","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice","volume":"64","author":"Gu","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2010.12.035_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2005.03.025","article-title":"Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice","volume":"46","author":"Gu","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2010.12.035_bib43","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","article-title":"Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity","volume":"96","author":"Hansson","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib44","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","article-title":"Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene","volume":"14","author":"Hansson","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib45","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1523\/JNEUROSCI.1830-07.2007","article-title":"Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease","volume":"27","author":"Heng","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib46","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/NEN.0b013e318198d320","article-title":"Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains","volume":"68","author":"Herndon","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib47","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2032dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2010.12.035_bib48","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2008.08.041","article-title":"Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice","volume":"157","author":"Hickey","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2010.12.035_bib49","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib50","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1601-183X.2007.00350.x","article-title":"Brain gene expression correlates with changes in behavior in the R6\/1 mouse model of Huntington's disease","volume":"7","author":"Hodges","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuron.2010.12.035_bib51","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","article-title":"A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration","volume":"23","author":"Hodgson","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2010.12.035_bib52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0300-9084(02)01398-6","article-title":"Protein aggregation in Huntington's disease","volume":"84","author":"Hoffner","year":"2002","journal-title":"Biochimie"},{"key":"10.1016\/j.neuron.2010.12.035_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/B:SCAM.0000007124.19463.e5","article-title":"Amyloid formation by mutant huntingtin: Threshold, progressivity and recruitment of normal polyglutamine proteins","volume":"24","author":"Huang","year":"1998","journal-title":"Somat. Cell Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","article-title":"A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease","volume":"57","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2010.12.035_bib55","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/01.WNL.0000096019.71649.2B","article-title":"Dosage effects of riluzole in Huntington's disease: A multicenter placebo-controlled study","volume":"61","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2010.12.035_bib56","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/01.WNL.0000133403.30559.FF","article-title":"Minocycline safety and tolerability in Huntington disease","volume":"63","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2010.12.035_bib57","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial","volume":"66","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neuron.2010.12.035_bib58","first-page":"1582","article-title":"Randomized controlled trial of ethyl-eicosapentaenoic acid in Huntington disease: The TREND-HD study","volume":"65","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jnr.1153","article-title":"Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene","volume":"65","author":"Ishiguro","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuron.2010.12.035_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","article-title":"Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model","volume":"127","author":"Jarabek","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.neuron.2010.12.035_bib61","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1471-4159.2005.03411.x","article-title":"Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease","volume":"95","author":"Jenkins","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2010.12.035_bib62","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/hmg\/9.17.2539","article-title":"Dramatic mutation instability in HD mouse striatum: Does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?","volume":"9","author":"Kennedy","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib63","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","article-title":"Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis","volume":"12","author":"Kennedy","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib64","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.870110310","article-title":"A controlled trial\u00a0of remacemide hydrochloride in Huntington's disease","volume":"11","author":"Kieburtz","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuron.2010.12.035_bib65","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1152\/jn.2001.86.6.2667","article-title":"Electrophysiological and morphological changes in striatal spiny neurons in R6\/2 Huntington's disease transgenic mice","volume":"86","author":"Klapstein","year":"2001","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuron.2010.12.035_bib66","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/hmg\/ddm133","article-title":"Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage","volume":"16","author":"Kuhn","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib67","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1523\/JNEUROSCI.21-23-09112.2001","article-title":"Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease","volume":"21","author":"Laforet","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/hmg\/8.2.173","article-title":"Analysis of germline mutation spectra at the Huntington's disease locus supports a mitotic mutation mechanism","volume":"8","author":"Leeflang","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib69","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-D-aspartate receptor activation in transgenic and\u00a0knockin mouse models of Huntington's disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuron.2010.12.035_bib70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/78054","article-title":"Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity","volume":"25","author":"Li","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1602\/neurorx.2.3.447","article-title":"The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies","volume":"2","author":"Li","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuron.2010.12.035_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/hmg\/10.2.137","article-title":"Neurological abnormalities in a knock-in mouse model of Huntington's disease","volume":"10","author":"Lin","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib73","doi-asserted-by":"crossref","first-page":"10428","DOI":"10.1523\/JNEUROSCI.19-23-10428.1999","article-title":"Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation","volume":"19","author":"Lione","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib74","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","article-title":"Decreased expression of striatal signaling genes in a mouse model of Huntington's disease","volume":"9","author":"Luthi-Carter","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib75","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/11.17.1927","article-title":"Polyglutamine and transcription: Gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib76","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2010.12.035_bib77","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0297-197","article-title":"Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation","volume":"15","author":"Mangiarini","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib78","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/70598","article-title":"Msh2 deficiency prevents in\u00a0vivo somatic instability of the CAG repeat in Huntington disease transgenic mice","volume":"23","author":"Manley","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib79","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","article-title":"Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease","volume":"18","author":"Matthews","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib80","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/cne.10295","article-title":"Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6\/2 transgenic mice","volume":"449","author":"Meade","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib81","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1006\/exnr.1999.7327","article-title":"Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease","volume":"162","author":"Menalled","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib82","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1523\/JNEUROSCI.22-18-08266.2002","article-title":"Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice","volume":"22","author":"Menalled","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib84","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2009.05.007","article-title":"Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models","volume":"35","author":"Menalled","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2010.12.035_bib85","first-page":"CD006456","article-title":"Therapeutic interventions for symptomatic treatment in Huntington's disease","volume":"3","author":"Mestre","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuron.2010.12.035_bib86","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neuroscience.2008.02.004","article-title":"Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6\/2 mouse","volume":"153","author":"Miller","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2010.12.035_bib87","doi-asserted-by":"crossref","first-page":"21900","DOI":"10.1073\/pnas.0912171106","article-title":"Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease","volume":"106","author":"Molero","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib88","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1023\/A:1010887421592","article-title":"Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington's disease mutation","volume":"29","author":"Morton","year":"2000","journal-title":"J. Neurocytol."},{"key":"10.1016\/j.neuron.2010.12.035_bib89","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.nbd.2008.11.015","article-title":"Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6\/2 mice","volume":"33","author":"Morton","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2010.12.035_bib90","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1523\/JNEUROSCI.20-13-05115.2000","article-title":"Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation","volume":"20","author":"Murphy","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib91","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1093-168","article-title":"De novo expansion of a (CAG)n repeat in sporadic Huntington's disease","volume":"5","author":"Myers","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib92","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.neuroscience.2003.08.053","article-title":"Molecular and behavioral analysis of the R6\/1 Huntington's disease transgenic mouse","volume":"122","author":"Naver","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2010.12.035_bib93","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/2.9.1475","article-title":"Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families","volume":"2","author":"N\u00f8rrem\u00f8lle","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib94","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1126\/science.1056784","article-title":"Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity","volume":"291","author":"Nucifora","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neuron.2010.12.035_bib95","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-4159.2006.04361.x","article-title":"Mitochondrial dysfunction in Huntington's disease: The bioenergetics of isolated and in\u00a0situ mitochondria from transgenic mice","volume":"101","author":"Oliveira","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2010.12.035_bib96","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","article-title":"Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A PET study","volume":"126","author":"Pavese","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neuron.2010.12.035_bib97","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/exnr.2002.7885","article-title":"Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease","volume":"175","author":"Peters\u00e9n","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib98","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/cne.21515","article-title":"R6\/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice","volume":"505","author":"Reiner","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib99","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1111\/j.1460-9568.2006.04871.x","article-title":"Huntingtin inclusions do not down-regulate specific genes in the R6\/2 Huntington's disease mouse","volume":"23","author":"Sadri-Vakili","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib100","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","article-title":"Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in\u00a0vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors","volume":"26","author":"Sagredo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2008.09.017","article-title":"Use of magnetic resonance imaging for anatomical phenotyping of the R6\/2 mouse model of Huntington's disease","volume":"33","author":"Sawiak","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2010.12.035_bib102","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mds.10229","article-title":"Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease","volume":"17","author":"Schiefer","year":"2002","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuron.2010.12.035_bib103","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.brainres.2004.06.005","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease","volume":"1019","author":"Schiefer","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2010.12.035_bib104","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2004.01.003","article-title":"Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice","volume":"187","author":"Schilling","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib106","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/hmg\/ddn211","article-title":"Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II\/III in YAC72 and R6\/2 transgenic mice partially model Huntington's disease patients","volume":"17","author":"Seo","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib107","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/nbdi.1996.0002","article-title":"Neurobiology of Huntington's disease","volume":"3","author":"Sharp","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuron.2010.12.035_bib108","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/hmg\/8.5.763","article-title":"A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice","volume":"8","author":"Shelbourne","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib109","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib110","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib111","doi-asserted-by":"crossref","first-page":"11402","DOI":"10.1073\/pnas.0503634102","article-title":"Absence of behavioral abnormalities and neurodegeneration in\u00a0vivo despite widespread neuronal huntingtin inclusions","volume":"102","author":"Slow","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib112","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib113","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.neuroscience.2008.09.020","article-title":"Progressive synaptic pathology of motor cortical neurons in a BAC transgenic mouse model of Huntington's disease","volume":"157","author":"Spampanato","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2010.12.035_bib114","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1111\/j.0953-816X.2004.03374.x","article-title":"Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6\/1 Huntington's disease transgenic mice","volume":"19","author":"Spires","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib115","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/cne.20680","article-title":"Chronology of behavioral symptoms and neuropathological sequela in R6\/2 Huntington's disease transgenic mice","volume":"490","author":"Stack","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib116","doi-asserted-by":"crossref","first-page":"12908","DOI":"10.1523\/JNEUROSCI.4318-07.2007","article-title":"Neuroprotective effects of synaptic modulation in Huntington's disease R6\/2 mice","volume":"27","author":"Stack","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib117","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","article-title":"The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription","volume":"97","author":"Steffan","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib118","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib119","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.neuroscience.2004.10.037","article-title":"Neuronal intranuclear inclusions and neuropil aggregates in HdhCAG(150) knockin mice","volume":"131","author":"Tallaksen-Greene","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2010.12.035_bib120","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1523\/JNEUROSCI.1396-07.2007","article-title":"Dopaminergic signaling and striatal neurodegeneration in Huntington's disease","volume":"27","author":"Tang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib121","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2010.12.035_bib122","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib123","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbr.2009.05.006","article-title":"Rule learning, visuospatial function and motor performance in the Hdh(Q92) knock-in mouse model of Huntington's disease","volume":"203","author":"Trueman","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2010.12.035_bib124","doi-asserted-by":"crossref","first-page":"8093","DOI":"10.1073\/pnas.110078997","article-title":"Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease","volume":"97","author":"Turmaine","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2010.12.035_bib125","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/8.5.839","article-title":"Impaired synaptic plasticity in mice carrying the Huntington's disease mutation","volume":"8","author":"Usdin","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.biopha.2009.06.020","article-title":"Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease","volume":"64","author":"Vamos","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuron.2010.12.035_bib127","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/35008142","article-title":"Delaying the onset of Huntington's in mice","volume":"404","author":"van Dellen","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2010.12.035_bib128","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in\u00a0the YAC128 mouse model of Huntington disease","volume":"14","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib129","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.expneurol.2005.07.021","article-title":"Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease","volume":"196","author":"Van Raamsdonk","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib130","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1523\/JNEUROSCI.0590-05.2005","article-title":"Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Van Raamsdonk","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib131","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainresbull.2006.10.015","article-title":"Progressive CAG expansion in the brain of a novel R6\/1-89Q mouse model of Huntington's disease with delayed phenotypic onset","volume":"72","author":"Vatsavayai","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuron.2010.12.035_bib132","doi-asserted-by":"crossref","first-page":"8973","DOI":"10.1523\/JNEUROSCI.2804-08.2008","article-title":"Altered information processing in the prefrontal cortex of Huntington's disease mouse models","volume":"28","author":"Walker","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib133","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-5-18","article-title":"Tetrabenazine is neuroprotective in Huntington's disease mice","volume":"5","author":"Wang","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neuron.2010.12.035_bib134","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ana.410400110","article-title":"Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington's disease","volume":"40","author":"Weeks","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuron.2010.12.035_bib135","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","article-title":"Length-dependent gametic CAG repeat instability in the Huntington's disease knock-in mouse","volume":"8","author":"Wheeler","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib136","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib137","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/hmg\/11.6.633","article-title":"Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice","volume":"11","author":"Wheeler","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib138","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/ddg056","article-title":"Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum","volume":"12","author":"Wheeler","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib139","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jmg.2007.050930","article-title":"Factors associated with HD CAG repeat instability in Huntington disease","volume":"44","author":"Wheeler","year":"2007","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuron.2010.12.035_bib140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2006.11.004","article-title":"The Hdh(Q150\/Q150) knock-in mouse model of HD and the R6\/2 exon 1 model develop comparable and widespread molecular phenotypes","volume":"72","author":"Woodman","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuron.2010.12.035_bib141","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00401-007-0287-5","article-title":"CAG repeat disorder models and human neuropathology: Similarities and differences","volume":"115","author":"Yamada","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuron.2010.12.035_bib142","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.neuron.2010.12.035_bib143","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.23-06-02193.2003","article-title":"Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease","volume":"23","author":"Yu","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2010.12.035_bib144","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2009.08.001","article-title":"Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease","volume":"94","author":"Z\u00e1dori","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuron.2010.12.035_bib145","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.neuroimage.2009.10.027","article-title":"Longitudinal characterization of brain atrophy of a Huntington's disease mouse model by automated morphological analyses of magnetic resonance images","volume":"49","author":"Zhang","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuron.2010.12.035_bib146","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/hmg\/ddi014","article-title":"Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: Neuronal selectivity and potential neuroprotective role of HAP1","volume":"14","author":"Zucker","year":"2005","journal-title":"Hum. Mol. Genet."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627310010858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627310010858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T06:56:09Z","timestamp":1760252169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627310010858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0896627310010858"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2010.12.035","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Huntington's Disease: Can Mice Lead the Way to Treatment?","name":"articletitle","label":"Article Title"},{"value":"Neuron","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuron.2010.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}